4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-030491
Chief Legal Officer sold 45,000 shares at an average $24.08 ($1,083,718)
- Chief Legal Officer acquired 45,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-03 | Option exercise | +15,000 | $10.66 | $159,900 | 158,618 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-03 | Sale | −10,661 | $24.46 | $260,745 | 147,957 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-03 | Sale | −4,339 | $24.91 | $108,074 | 143,618 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-04 | Option exercise | +15,000 | $10.66 | $159,900 | 158,618 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-04 | Sale | −13,721 | $23.61 | $323,891 | 144,897 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-04 | Sale | −1,279 | $24.47 | $31,296 | 143,618 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-05 | Option exercise | +15,000 | $10.66 | $159,900 | 158,618 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-05 | Sale | −14,502 | $23.97 | $347,584 | 144,116 | D |
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-05 | Sale | −498 | $24.36 | $12,129 | 143,618 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-03 | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 50,416 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-04 | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 35,416 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2021-05-05 | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | 20,416 | D | ||
| Open-market sales · 45,000 sh · avg $24.08 · $1,083,718 | |||||||
Loading xslF345X03/doc4.xml…